LFCR Lifecore Biomedical PE ratio, current and historical analysis
The current PE ratio of LFCR cannot be calculated, as the latest EPS of -$0.5 is negative. Lifecore Biomedical's last PE ratio on record was 27.27 in August 2024.
LFCR PE ratio history
The mean historical PE ratio of Lifecore Biomedical over the last ten years is 88.37. Looking back at the last ten years, LFCR's PE ratio peaked in the May 2019 quarter at 942, with a price of $9.42 and an EPS of $0.01. The May 2024 quarter marked the lowest point at 14.05, with a price of $5.62 and an EPS of $0.4.
Lifecore Biomedical PE ratio by year
Maximum annual increase: 5,934.59% in 2019
Maximum annual decrease: -62.88% in 2012
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 14.05 | N/A | $5.62 | $0.4 |
| 2023 | N/A | N/A | $7.94 | -$3.32 |
| 2022 | N/A | N/A | $9.87 | -$3.97 |
| 2021 | N/A | N/A | $11.97 | -$1.1 |
| 2020 | N/A | N/A | $10.67 | -$1.31 |
| 2019 | 942 | 5,934.59% | $9.42 | $0.01 |
| 2018 | 15.61 | -55.4% | $14.05 | $0.9 |
| 2017 | 35 | N/A | $13.65 | $0.39 |
| 2016 | N/A | N/A | $11.46 | -$0.43 |
| 2015 | 28.58 | 71.34% | $14.29 | $0.5 |
| 2014 | 16.68 | 4.58% | $12.01 | $0.72 |
| 2013 | 15.95 | 10.53% | $13.88 | $0.87 |
| 2012 | 14.43 | -62.88% | $7.07 | $0.49 |
| 2011 | 38.87 | -5.82% | $5.83 | $0.15 |
| 2010 | 41.27 | 82.61% | $6.19 | $0.15 |
Lifecore Biomedical PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Nov 2024 | N/A | N/A | $7.31 | -$0.5 |
| Aug 2024 | 27.27 | 94.09% | $6 | $0.22 |
| May 2024 | 14.05 | N/A | $5.62 | $0.4 |
| Feb 2024 | N/A | N/A | $8.07 | -$0.67 |
| Nov 2023 | N/A | N/A | $7.51 | -$2.38 |
| Aug 2023 | N/A | N/A | $8.39 | -$3.28 |
| May 2023 | N/A | N/A | $7.94 | -$3.32 |
| Feb 2023 | N/A | N/A | $5.85 | -$3.9 |
| Nov 2022 | N/A | N/A | $8.37 | -$3.15 |
| Aug 2022 | N/A | N/A | $10.19 | -$4.02 |
| May 2022 | N/A | N/A | $9.87 | -$3.97 |
| Feb 2022 | N/A | N/A | $11.54 | -$2.87 |
| Nov 2021 | N/A | N/A | $8.67 | -$2.47 |
| Aug 2021 | N/A | N/A | $10.87 | -$1.62 |
| May 2021 | N/A | N/A | $11.97 | -$1.1 |
LFCR average PE ratio chart
LFCR PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPTN OptiNose Inc | N/A | $92.01M |
| OPK Opko Health Inc | N/A | $1.21B |
| ORGO Organogenesis Holdings Inc | N/A | $629.07M |
| LFCR Lifecore Biomedical Inc | N/A | $242.52M |
Frequently asked questions
What is Lifecore Biomedical's PE ratio?
The current price to earnings ratio of LFCR cannot be determined, as its EPS of -$0.5 is negative.
What is the highest PE ratio for LFCR?
The highest quarterly PE ratio in the last ten years has been 942 and it was in the May 2019 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.